Indian secondaries: getting across the line

A handful of successful GP-led processes, involving household names such as CDC and Coller Capital, represent a significant step forward for the Indian secondaries market in 2018.

6 December 2018•4 mins read
Feature image
LinkedInXEmail

SECONDARIES INVESTOR

Register to unlock this content

  • Daily global secondaries market news and intelligence
  • Curated insights to keep you ahead of GP-led and LP-led secondaries
  • Faster, data-driven decision making powered by our AI interface, 'Ask PEI'
  • Access to proprietary research and reports
  • Selected fund performance and investor activity data
LinkedInXEmail

Related articles